Clinical Trial Update: A Study of LY573636-Sodium in the Treatment of Patients With Metastatic Soft Tissue Sarcoma [Phase 2]

View source ↗

Summary

Phase 2 trial investigating LY573636-Sodium for metastatic soft tissue sarcoma has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• LY573636-sodium

Snippet

Sponsor: Eli Lilly and Company | Conditions: Sarcoma, Soft Tissue | Phase 2 | Status: COMPLETED | Results posted: 2018-05-02